Cargando…
Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
Drug repositioning has been attracting increasingly attention for its advantages of reducing costs and risks. Statistics showed that around one quarter of the marketed drugs are organohalogens. However, no study has been reported, to the best of our knowledge, to aim at efficiently repositioning org...
Autores principales: | Li, Yisu, Guo, Binbin, Xu, Zhijian, Li, Bo, Cai, Tingting, Zhang, Xinben, Yu, Yuqi, Wang, Heyao, Shi, Jiye, Zhu, Weiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977465/ https://www.ncbi.nlm.nih.gov/pubmed/27501852 http://dx.doi.org/10.1038/srep31074 |
Ejemplares similares
-
Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023) -
Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-Raf(V600E)/KDR Inhibitors Using Docking and 3D-QSAR Approaches
por: Liu, Hai-Chun, et al.
Publicado: (2015) -
D3PM: a comprehensive database for protein motions ranging from residue to domain
por: Peng, Cheng, et al.
Publicado: (2022) -
An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
por: McMinn, Brooke, et al.
Publicado: (2019) -
The mechanism of activation of monomeric B-Raf V600E
por: Maloney, Ryan C., et al.
Publicado: (2021)